Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging.
Vorster M, Maes A, Wiele Cv, Sathekge M. Semin Nucl Med. 2016 Sep;46(5):436-47.
Radiopharmaceuticals in positron emission tomography: present situation and future perspectives
Olivas Arroyo C. Radiologia. 2016 Aug 31. pii: S0033-8338(16)30111-4.
Present and future of PET radiopharmaceuticals. Elsinga P. Nucl Med Review 2012. 15 Supp C13-C16
New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B1, Halldin CQ J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90.
Synthesis of oncological [11C]radiopharmaceuticals for clinical PET
Lodi F, Malizia C, Castellucci P, Cicoria G, Fanti S, Boschi S. Nucl Med Biol. 2012 May;39(4):447-60. Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
Basis and principles of radiopharmaceuticals for PET/CT. Wadsak W, Mitterhauser M. Eur J Radiol. 2010;73(3):461-469
Stability of 11C-labeled PET radiopharmaceuticals.
Fukumura T, Nakao R, Yamaguchi M, Suzuki K. Appl Radiat Isot. 2004 Dec;61(6):1279-87.